BiondVax advances its growth strategy towards a new pipeline based on innovative VHH antibodies
- Tuesday, October 19, 2021, 7:12
- PR Newswire
- Add a comment
JERUSALEM, Oct. 19, 2021 /PRNewswire/ — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today announced the signing of a term…
About the Author
admin has written 20771 stories on this site.